251 / 1851
CROSS Trial
Overall survival
According to
histology
OS improvement
for both histologies
Shapiro, Lancet Oncol 2015; 16: 1090–98
pCR: 29%
R0: 92 vs 65%
Post-op mortality: 4% in both groups
Overall survival
A significant improvement in favor of pre-op. RT-CT